ResearcherNational and Kapodistrian University of AthensActive in the last 2 years
Nikolaos Garmpis
Matched on ORCID iD 0000-0001-9980-0056; OpenAlex author ID A5087114853. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 6
- International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
- Liquid biopsy in pancreatic ductal adenocarcinoma from diagnostic accuracy to clinical utility. First author DOI 10.3389/fonc.2026.1962181↗
- Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer? Co-author DOI 10.21873/invivo.12736↗
- The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. Co-author DOI 10.3390/genes13101868↗
- Ethical Dilemma: Is it Worthwhile Operating an End-Stage Pancreatic Cancer Patient with Acute Mesenteric Artery Ischemia? First author DOI 10.15388/amed.2021.28.2.17↗
- Histone Deacetylase (HDAC) Inhibitors: Current Evidence for Therapeutic Activities in Pancreatic Cancer. First author PMID 26026072↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christos Damaskos · 5 shared papers, 2015–2026 · strength 0.89
- Paper Liquid biopsy in pancreatic ductal adenocarcinoma from diagnostic accuracy to clinical utility. DOI 10.3389/fonc.2026.1962181↗
- Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
- Paper Ethical Dilemma: Is it Worthwhile Operating an End-Stage Pancreatic Cancer Patient with Acute Mesenteric Artery Ischemi… DOI 10.15388/amed.2021.28.2.17↗
- Konstantinos Kossenas · 1 shared paper, 2026 · strength 0.43
- Panagiotis Sarantis · 2 shared papers, 2022 · strength 0.27
- Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736↗
- Evangelos Koustas · 2 shared papers, 2022 · strength 0.27
- Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736↗
- Efstathios Antoniou · 2 shared papers, 2021–2022 · strength 0.26
- Paper Ethical Dilemma: Is it Worthwhile Operating an End-Stage Pancreatic Cancer Patient with Acute Mesenteric Artery Ischemi… DOI 10.15388/amed.2021.28.2.17↗
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736↗
- Gregory P. Kouraklis · 2 shared papers, 2015–2022 · strength 0.17
- Eleni-Myrto Trifylli · 1 shared paper, 2022 · strength 0.15
- Michalis V. Karamouzis · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.